Department of obstetrics, Femme Mère Enfant Hospital
Lyon, 69677, France
NCT Number: NCT03227536
This is an historic cohort study based on the birth and delivery register of the HFME maternity ward. This study aim at understanding the evolution of asphyxia at birth, at all gestational ages, identifying causes and describing neonatal outcomes since 2000, when a second line strategy for foetal surveillance (fetal ECG) and systematic umbilical acid-gas cord blood were introduced in our maternity ward.
The investigator's hypothesis was that the neonatal asphyxia decrease could be due to 3 main factors including second line strategy introduction, systematic umbilical cord acid-base implementation and improvement in antenatal risk factor screening for asphyxia. The investigator's second hypothesis was that neonatal prognosis in neonates with acidosis was improved with systematic early after birth EEG evaluation, allowing early treatment and surveillance.
Looking for future studies?
Notify MeUp to 1 hour
All sexes
Observational
Lyon, 69677, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 months
Neonatal asphyxia define as fetal death, neonatal death, NICU transfer, neonatal seizure, umbilical-artery blood pH ≤ 7.05 with a base deficit ≥ 12 mmol per liter, intubation for ventilation at delivery or neonatal encephalopathy
Hospices Civils de Lyon
Other
Asphyxia at Birth : Evolution of Birth Asphyxia Rate, Etiologies and Neonatal Outcome From 2000 to 2016
Acronym: ABC-NEO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06429111
Asphyxia Neonatorum, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Vila-real, Castellon, Spain
View Trial DetailsNCT03210194
Asphyxia Neonatorum, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Lima, Peru
View Trial DetailsNCT03254628
Asphyxia Neonatorum, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
View Trial DetailsNCT02347241
Asphyxia Neonatorum, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Oslo, Norway
View Trial Details